Abstract
1. Abstract: Cross contamination is a major concern in pharmaceutical industry, especially with long term dosing and accumulative possible effects. The risk is dependent on many factors that can be divided into three main groups: - 1.1. Individual related - starting from the genomic makeup, age, gender, environment, even their diet and psychological state, which in return, alters the individual response to contamination and to any pharmaceutical API. 1.2. Formulation related: - like it`s clean-ability, solubility of the API, batch size, maximum daily dose or inactive materials and most importantly the PDE (permitted daily exposure) of the API/s, which covers the toxicological profile of this API, including its genotoxic, reproductive toxicity, sensitizing potential or any adverse effects that would result from long or short term cross contamination. 1.3. Facility related - As the machine SSA (Shared Surface area between product (A) as the contaminant and Product (B) as the contaminated). The following approach is based upon EMA recommendations on health based exposure limits. It aims to address all the three groups mentioned above to give a scientific rational, on how to evaluate the cleaning process efficiency. Keywords: - Cleaning validation; Cross contamination risk assessment; health-based exposure limits; Chemical swab limits; Chemical contamination. Abbreviations:- PDE( Permitted daily exposure), MACO( Maximum allowed carryover), SAL( Surface area limit), SSA(Shared surface area, ICH( International committee of harmonization), API( Active pharmaceutical ingredient)
- Bracketing Cleaning Validation Latest update
- Cleaning Validation
- Cross Contamination risk assesment
- MACO: Maximum allowed carryover
- Permitted daily exposure limits (PDE)
- SAL : Surface Area Limit
- Received May 10, 2018.
- Accepted October 4, 2018.
- Copyright © 2018, Parenteral Drug Association
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.